Pharmacosmos Sustainability Profile
Pharmacosmos A/S, a leading player in the pharmaceutical industry, is headquartered in Denmark (DK) and operates extensively across Europe and beyond. Founded in 1983, the company has established itself as a specialist in iron deficiency treatment, focusing on innovative therapies that enhance patient care. Pharmacosmos is renowned for its core products, including intravenous iron formulations, which are distinguished by their efficacy and safety profiles. The company’s commitment to research and development has led to significant milestones, positioning it as a trusted partner in the healthcare sector. With a strong market presence and a dedication to improving patient outcomes, Pharmacosmos continues to make notable contributions to the treatment of iron deficiency and related conditions.
DitchCarbon Score
How does Pharmacosmos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmacosmos's score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharmacosmos's reported carbon emissions
Pharmacosmos, headquartered in Denmark (DK), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Pharmacosmos may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information at this time. As the industry increasingly prioritises sustainability, Pharmacosmos's future climate initiatives will be crucial for aligning with global climate goals and expectations.
How Carbon Intensive is Pharmacosmos's Industry?
How Carbon Intensive is Pharmacosmos's Location?
Pharmacosmos's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pharmacosmos has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
